June 3 (Reuters) - Mineralys Therapeutics Inc MLYS.O:

• MINERALYS THERAPEUTICS ANNOUNCES REPURCHASE OF ROYALTY OBLIGATIONS IN TANABE LICENSE AGREEMENT AND CONCURRENT FINANCING

• MINERALYS THERAPEUTICS - TO REPURCHASE LORUNDROSTAT ROYALTY OBLIGATION FOR $200 MILLION UPFRONT, UP TO $100 MILLION IN MILESTONES

• MINERALYS THERAPEUTICS - SECURES $500 MILLION SENIOR SECURED TERM LOAN FACILITY FROM PHARMAKON ADVISORS

• MINERALYS THERAPEUTICS - PRICES $150 MILLION COMMON STOCK OFFERING

Source text: ID:nGNX9t1NND

Further company coverage: MLYS.O